Articles On Althea Group Holdings (ASX:AGH)

Althea Group (ASX: AGH) subsidiary Peak Processing Solutions will immediately start commercial operations at its high-tech Ontario facility after securing a cannabis processing licence from Canadian authorities. The Standard Processing Li...

Althea Group (ASX: AGH) subsidiary Peak Processing Solutions will immediately start commercial operations at its high-tech Ontario facility after securing a cannabis processing licence from Canadian authorities. The Standard Processing Li...

ASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re-classify low-dose cannabidiol (CBD) products. The TGA has made an interim decision to down schedule CBD products, including oil and pills,...

In a move that would appear to enthuse the ASX-listed cannabis stocks, the Therapeutic Goods Administration (TGA) has announced an interim decision to reclassify cannabidiol (CBD) products so they can be purchased over the counter at pharma...

The market may be sinking lower today but that hasn’t stopped ASX cannabis shares from storming higher. For example, at the time of writing the Althea Group Holdings Ltd (ASX: AGH) share price is up 8% to 54 cents. Elsewhere, the Auscann G...

ASX cannabis shares faded from the spotlight in 2020 as the coronavirus pandemic took over. But the Australian medical marijuana companies have been working through COVID-19 disruptions as they look to scale their businesses. Some have bee...

Cannabis shares were considered a fad for a while. Now, they’ve proved they’re here to stay. As the Australian medicinal cannabis industry grows, ASX cannabis companies are refining their strategies. While some are focused on cultivation a...

Two weeks since securing a new patient referral agreement and approvals for more clinic locations, medicinal cannabis company Althea Group (ASX: AGH) has turned its attentions to making commercial progress online. In a statement this mornin...

Pharmaceutical company Althea Group (ASX:AGH) had some interesting distribution news, announcing the Australian-first launch of an online channel for its medicinal cannabis products. The company says its Althea Concierge service, which has...

A web-based technology platform has long been the centrepiece of medicinal cannabis company Althea Group's (ASX: AGH) customer experience strategy, providing educational information and prescription pathways for patients and doctors alike....

The Althea Group Holdings Ltd (ASX: AGH) share price is on watch this morning after the company announced it has launched online sales of medicinal cannabis. Patients can now order products online via the ‘Althea Concierge’ platform and ha...

Pharma company Althea Group (ASX: AGH) has unveiled a string of advances in the UK citing “significant progress” in securing a new patient referral agreement, further approvals for more clinic locations and an agreement with an independent...

The Althea Group Holdings Ltd (ASX: AGH) share price is on the rise today. This follows an announcement that company’s subsidiary has entered into a cannabis beverage production agreement. Althea’s subsidiary, Peak Processing Solutions, ha...

ASX cannabis shares have staged a mixed recovery since March. The Althea Group Holdings Ltd (ASX: AGH) and Cann Group Ltd (ASX: CAN) shares have had strong comebacks but the Auscann Group Holdings Ltd (ASX: AC8) price has been softer. Coro...

North American pot stocks are roaring back from lows in March but the same cannot be said for their antipodean counterparts, many of which continue to wallow. The New Cannabis Ventures Global Cannabis Stock Index soared 26 per cent last wee...

Queensland medical marijuana group THC Global (ASX:THC) has started selling its products in Australia, with the first one available by prescription under the government’s Special Access Scheme (SAS). THC is one of several companies which an...

For small cap stock investors, the COVID-19 risk outlook is at an interesting juncture heading into June reporting season. At current levels, the ASX Small Ords Index has bounced by an impressive 40 per cent from its March 23 low of 1,825 p...

THC Global Group (ASX: THC) will pay $3 million in shares and cash to acquire the Tetra Health network of clinics which provide access to legal medicinal cannabis. Tetra’s network comprises over 630 referring and prescribing physicians, as...

Phillip Capital has rated ASX cannabis share Althea Group Holdings Ltd (ASX: AGH) a buy with a target price of 57 cents. Shares in the medical marijuana distributor are currently trading at 39 cents. The broker is positive on the company,...

ASX cannabis shares have faced a difficult few months. Struck by a capital crunch earlier this year, cannabis shares were then hammered in the March downturn. Last year wasn’t much better, with the vaping crisis and slow roll out of Canada...

Pharmaceutical company Althea Group (ASX: AGH) has added Germany to its list of active markets following the signing of a 3-year supply and distribution agreement with German wholesaler Nimbus Health. Althea will now see its products sold i...

ASX cannabis shares have proven to be susceptible to coronavirus, with valuations slashed in the recent market downturn. This is the second crisis to hit cannabis shares in the past year, after the “vape crisis” in late 2019.  The current...

The S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is storming higher on Tuesday. The benchmark index is currently up 2.5% to 5,419.9 points. Three healthcare shares that are vastly outperforming the benchmark i...

ASX cannabis shares have been hammered in the market downturn as investors turn to safe-haven assets. But while the market has been distracted by the fallout from the coronavirus pandemic, ASX cannabis shares have been quietly expanding th...

Pharmaceutical company Althea Group (ASX: AGH) has published an interim update regarding its active businesses in Australia, Canada and the UK, declaring that February bettered January as the company’s second-best month on record. The compa...

The Althea Group Holdings Ltd (ASX: AGH) share price has fallen materially over the last few weeks following the coronavirus-induced market volatility. In fact, it isn’t just Althea which has been impacted. The likes of Auscann Group Holdi...

The THC Global Group Ltd (ASX: THC) share price has returned from its trading halt and is zooming higher on Tuesday morning. At the time of writing the cannabis company’s shares are up 11% to 34.5 cents. Why was the THC Global share price...

Reporting season wrapped up last week with the S&P/ASX 200 Index (INDEXASX: XJO) falling more than 10% from recent highs. As fears around the spread of coronavirus escalated, the contagion of fear infected markets, prompting a major c...

The Althea Group Holdings Ltd (ASX: AGH) share price is sinking lower today as the medicinal cannabis producer released its half-year results.  After opening relatively flat this morning, Althea shares are now down 7.69% to $0.30 apiece. A...

As cannabis regulation in the US inches forward, there are now 11 states where the drug is legal for both medical and recreational purposes. An important new player — New York — is expected to become the 12th state later this year. And in t...

The S&P/ASX 200 index is on course to record a strong gain on Tuesday. In afternoon trade the benchmark index is up 0.7% to 7,062.9 points. Four shares that are climbing more than most today are listed below. Here’s why they are surgin...

Pharmaceutical company Althea Group (AGH) has enjoyed strong patient growth throughout January The first month of 2020 became the second-best on record for the company, with 572 new patients added to Althea’s database Almost 5000 patients...

The Althea Group Holdings Ltd (ASX: AGH) share price has stormed higher in morning trade. At the time of writing the cannabis company’s shares are up 4% to 39 cents. Why is the Althea share price pushing higher? Investors have been buying...

The breakdown in the corporate North American marijuana sector is having ramifications in the Australian industry, and it’s unclear how big an impact the ructions will continue to have. Lower than expected take up of recreational marijuana...

Cann Group (ASX:CAN) is pulling back from its original ambitious Mildura cannabis growing warehouse, saying a global oversupply has led it to change plans. Furthermore, major shareholder Aurora says it won’t participate in any new funding r...

The Cann Group Ltd (ASX: CAN) share price was on form again on Monday and recorded another strong gain. The medicinal cannabis company’s shares raced 13% higher to end the day at $1.07. This latest gain means that Cann Group’s shares have...

The MGC Pharmaceuticals Ltd (ASX: MXC) share price has been a strong performer on Thursday. In morning trade the cannabis company’s shares have jumped 12% higher to 3.7 cents. Why is the MGC Pharma share price jumping higher today? Hot on...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Tuesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 1.39% t...

Medicinal cannabis company Althea (ASX: AGH) had a stellar finish to an eventful 2019 with more than 4,000 patients prescribed in Australia. Founded by Joshua Fegan (pictured), who won Trailblazer of the Year at the Melbourne Young Entrep...

Cann Group’s (ASX: CAN) manufacturer has started making cannabis resin from the company’s plants, and it should be ready for sale by March. The resin needs to be tested for stability before being sold as oil and as an active pharmaceutical...

Althea Group Holdings Ltd (ASX: AGH) shares have jumped as much as 6% higher this morning after a strong operational update from the ASX cannabis company. At the time of writing, Althea shares are trading for 48 cents, up 3.26%. What did...

The Cann Group Ltd (ASX: CAN) share price was the best performer on the All Ordinaries index on Monday before being placed in a trading halt. The cannabis company’s shares were up as much as 28% to $1.03 at one stage today. And were 25.5%...

Last year was a bear market for cannabis stocks globally. During 2019, the excitement that had followed the legalisation of marijuana in many jurisdictions was replaced by cautio as investors realised early forecasts weren’t necessarily ma...

The Cann Group Ltd (ASX: CAN) share price has started the week on an incredibly positive note. At the time of writing the cannabis company’s shares are the best performers on the All Ordinaries index. In afternoon trade they are up a massi...

Marijuana is the hottest herb on the planet right now, but while investing in medical cannabis stocks could make you a fortune, it could also risk the house. After a flurry of activity on the ASX in 2017 as the sector kicked off following l...

An Initial Public Offering (IPO) is a process in which a private company offers its shares to the public through stock issuance. An IPO is the best way for a company to raise a substantial amount of capital to expand its operations. The fun...

The Elixinol Global Ltd (ASX: EXL) share price looks set to end the week on a very disappointing note. The cannabis company’s shares are down over 9% to a 52-week low of 58 cents this afternoon. This means Elixinol Global’s shares have fal...

Cannabis shares have had a bad run in the second half of 2019. Prices have retreated from the highs seen earlier in the year, led lower by North American cannabis stocks. Could 2020 see a reversal in fortunes? We take a look at 2 ASX cann...

The cannabis industry is one of the most debated sectors at a global scale, and significant progress has been seen in this industry worldwide. Medicinal cannabis products manufactured in Australia must be created under a Good Manufacturing...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Tuesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.04% to ...